Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment Patterns Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting.

Kavita R Sail, MS, PhD, Lei Chen, MD, PhD, James Jackson, PharmD, MPH, Solveig G. Ericson, MD, PhD, Sally Haislip, RPh, Tamara Ibison, RN, James Gilmore, PharmD, Mansoor N Saleh, MD

Blood (2012) 120 (21): 3179.

https://doi.org/10.1182/blood.V120.21.3179.3179

Published: 2012

Journal Articles

Monitoring Patterns and Subsequent Outcomes Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting

James Jackson, PharmD, MPH, Lei Chen, MD, PhD, Kavita R Sail, MS, PhD, Solveig G. Ericson, MD, PhD, Sally Haislip, RPh, Joyce Sharpe, RN, James Gilmore, PharmD, Mansoor N Saleh, MD

Blood (2012) 120 (21): 2066.

https://doi.org/10.1182/blood.V120.21.2066.2066

Published: 2012

Journal Articles

Evaluation of Patient Outcome Benefits and Resource Utilization Associated with a Hematopathologist-Directed Workflow for Diagnosis of Hematological Malignancies

John F Leite, PhD, Sudipto Sur, PhD, Bashar Dabbas, MD, James Gilmore, PharmD, Sally Haislip, RPh, Mike I. Nerenberg, MD

Blood (2011) 118 (21): 3127.

https://doi.org/10.1182/blood.V118.21.3127.3127

Published: 2011

Journal Articles

Likelihood of a Subsequent Chemotherapy Induced Nausea and Vomiting Event In Patients with Hematologic Malignancies Receiving Chemotherapy.

Bruce Feinberg, DO, Lee S. Schwartzberg, MD, FACP, James Gilmore, PharmD, Sally Haislip, RPh, James Jackson, PharmD, MPH, Gagan Jain, PhD, Sanjeev Balu, PhD, MBA, Deborah Buchner, PhD

Blood (2010) 116 (21): 3819.

https://doi.org/10.1182/blood.V116.21.3819.3819

Published: 2010

Journal Articles

Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS

Bruce Feinberg, James Gilmore, Sally Haislip, Carlos M. Franco, MD, Tom Gondesen, Mansoor N. Saleh, MD

Blood (2008) 112 (11): 2380.

https://doi.org/10.1182/blood.V112.11.2380.2380

Published: 2008

NARROW

Treatment Patterns Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting.

Monitoring Patterns and Subsequent Outcomes Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting

Evaluation of Patient Outcome Benefits and Resource Utilization Associated with a Hematopathologist-Directed Workflow for Diagnosis of Hematological Malignancies

Likelihood of a Subsequent Chemotherapy Induced Nausea and Vomiting Event In Patients with Hematologic Malignancies Receiving Chemotherapy.

Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS

Email alerts

ASH Publications

American Society of Hematology

Treatment Patterns Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting.

Monitoring Patterns and Subsequent Outcomes Among Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) Treated with Imatinib in a Community Setting

Evaluation of Patient Outcome Benefits and Resource Utilization Associated with a Hematopathologist-Directed Workflow for Diagnosis of Hematological Malignancies

Likelihood of a Subsequent Chemotherapy Induced Nausea and Vomiting Event In Patients with Hematologic Malignancies Receiving Chemotherapy.

Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only